Ondansetrón Aristo (Ondansetron)

Ondansetron, the active ingredient in Ondansetrón  , is a serotonin 5‑HT3 receptor antagonist presented as a 4 mg oral tablet for oral use. It helps prevent nausea and vomiting caused by chemotherapy, radiotherapy and postoperative recovery in adult and paediatric patients.

GNH USA supplies Ondansetrón   as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Ondansetron is used across several clinical pathways that involve nausea and vomiting control. - Chemotherapy‑induced nausea and vomiting (CINV): reduces the frequency and severity of acute and delayed episodes. - Radiation‑induced nausea and vomiting (RINV): helps control the onset of nausea during and after radiotherapy. - Post‑operative nausea and vomiting (PONV): lowers the incidence of nausea and vomiting after surgical procedures. - Pregnancy‑related hyperemesis gravidarum (off‑label use): may be considered when conventional therapy fails, under specialist specialist c​.

Common Side Effects: - Headache   - Constipation   - Diarr  

Serious or Rare Side Effects: -  QT    

Ondond      

...